IMG_9996_edited.jpg

A new gold standard for addiction assessment,
prevention, and chronic illness management

Automating Addiction Assessment to Guide Tele-Health

Compris’s Evidence-Based Components

Current substance use assessment tools share these major flaws:

  • They are based on very limited evidence-based research.

  • Their single illness parameter focus--acute illness severity--does not risk-stratify the population.

  • By ignoring enduring risk factors, they are unable to predict the likelihood of developing an addiction, and therefore have no role in prevention.

  • Without risk factor analysis, they can’t predict or inform sustained remission either.

  • Level of care placement for severe illness acuity, without considering enduring risk and current resilience, favors residential treatment with typically higher costs and poor outcomes.

  • Even the better tools, (eg. The ASAM Criteria) are built around acute illness expression and offer limited guidance and utility for outpatient use.​

  • This contributes to treatment provider disparities in utility, standardization, willingness to treat, and treatment effectiveness.

  • Current answers don't differentiate which medication and duration fit which patients.

  • The more comprehensive assessments are inefficient and less accessible.

  • Lastly, treatment programs lacking risk-stratified data are unable to evaluate their own effectiveness with “apples to apples” comparisons.  

Compris, as its French meaning implies, understands that any comprehensive addiction assessment must include the following seven well established illness parameters: prevention, acuity, severity, risk, resilience, readiness and remission. Where available, Compris applies validated measures to its algorithms thereby creating the first complete prevention and long-term addiction management guide. 

In doing so, Compris: 

  • Brings more primary care providers into the fight by giving them an assessment and treatment plan based on the most current research.

  • Is available online 24/7, can be completed in 15-30 minutes, and enables access to addiction assessment and treatment across cultural, geographic, and economic barriers.

How is Compris's diagnostic assessment different?

 

Compris' carefully designed algorithms translate evidence-based lifetime risk and resilience factors, substance use illness acuity and severity, motivation and denial, into the first complete prevention and long-term addiction management guide. It includes the following:

  • DSM-5: Compris uses DSM-5 criteria to capture illness expression across five timelines (30-day, 1-3-months, 4-11-months, 1-4-years, and 5+ years). This is done intentionally to underscore the nature of addictions as chronic illnesses, with increasing debility over time, and the need to track a longer view of the diagnostics and evolving care needs.

  • Heaviness of Smoking Index (HSI): Embedded in Compris’s algorithm is the evidence-based HSI for diagnosing nicotine dependence across five timelines.

  • Compris BUILD Model©: Compris’ foremost assessment innovation is a new model that risk-stratifies the likelihood of illness onset, severity, and addiction chronicity. The BUILD Model© combines and rank orders the influences of five evidence-based components: Blueprint (genetics and epigenetics), User Traits, Injured developing brain, Life stress and trauma, and Damage from use.

  • Substance Use Risk Profile Scale (SURPS): Compris embeds the SURPS (used by permission), which measures four personality traits (negative thinking, anxiety, impulsivity, and sensation-seeking) associated with increased risk for substance-specific use.

  • Patient Health Questionnaire (PHQ-2): Brief depression screen, with additional acute suicidal and homicidal ideation added to target imminent safety needs.

  • Food Insecurity screen (FI): One of many social determinants of health routinely captured.

  • Compris Resilience Profile©: Compris’ Resilience model introduces four kinds of resiliences: Objective, Personal, Relational, and Active; each one defined by seven positive features either currently present, underdeveloped, or missing in a person’s life. Resilience training is a key treatment and recovery component of care.

  • Compris Motivation Scale©: Compris’ readiness for recovery engagement identifies three primary motivation types (negative, conflicted, and positive) along an 11-point continuum that best describes a person's current inner motivation for wellness recovery.

  • Motivators to engage: Compris includes a validated Jung/Myers Model of Personality type to optimize provider / client engagement, adapted with permission from iconnecthealth.com.

  • Compris Prevention Guide: Compris is the first addiction assessment tool with risk and resilience-informing guidance to help prevent illness onset as well as prevent relapses. Prevention remains the most cost-effective strategy for managing any illness before onset. Recommended resources for preventing illness expression and sustaining remission include targeted MET/CBT risk-based resilience training. Compris' guidance incorporates the level of addiction risk including substance-specific personality traits (SURPS), illness severity, and resilience resources.

  • Compris Treatment Plan: Five interactive parameters inform sustained remissions: acuity, severity, risk, resilience, and readiness.

  1. Level of Care Placement: Compris’ Level of Care placement is consistent with the ASAM criteria, including detox, and co-occurring illness, but also informed by lifetime risk level and resilience factors, enabling a more nuanced range of outpatient recommendations. This encourages an increasing number of those with significant illness, who would otherwise be placed in residential or inpatient settings to be safely treated in outpatient programs (IOP, PHP, OBOT).

  2. Medication Recommendations: Three evidence-based medications (methadone, buprenorphine, and naltrexone) are selectively recommended from risk factor analysis that helps clarify which individuals are more likely to complete the required detox and benefit from extended release antagonist (naltrexone) therapy vs replacement agonists (methadone / buprenorphine) that don’t require detox.

  3. Support groups and focused counseling: Long established contributors to sustained remission include ongoing 12-step, SMART, etc. in combination with targeted counseling or co-occurring counseling for those with co-morbid brain illnesses (depression, bi-polar, etc.).

  4. Additional recommendations: Psychiatric consults, nicotine cessation, and benzo/barbiturate management.